Predictors of clinically aggressive recurrent respiratory papillomatosis

P Weinberger, P Robb, H Carlson… - …, 2009 - augusta.elsevierpure.com
Objective: To determine possible predictive factors for clinically aggressive recurrent
respiratory papillomatosis (RRP). Study Design: Retrospective cohort study at a tertiary …

Current and future management of recurrent respiratory papillomatosis

R Ivancic, H Iqbal, B deSilva, Q Pan… - Laryngoscope …, 2018 - Wiley Online Library
Objectives Recurrent respiratory papillomatosis (RRP) is a chronic disease of the respiratory
tract that occurs in both children and adults. It is caused by the human papillomavirus (HPV) …

Biologics for the treatment of recurrent respiratory papillomatosis

CT Allen - Otolaryngologic Clinics of North America, 2021 - oto.theclinics.com
Recurrent respiratory papillomatosis (RRP) is a neoplastic disorder that manifests as
papillomatous growths in the upper aerodigestive tract. The symptom profile, socioeconomic …

Stabilization of Recurrent Respiratory Papillomatosis with Pembrolizumab Therapy: A Case Report

MP Strohl, CA Rosen - Journal of Voice, 2023 - Elsevier
Recurrent respiratory papillomatosis (RRP) is a benign neoplastic disease of the respiratory
tract that is caused by human papilloma virus (HPV). The current standard of care is surgical …

Tracheobronchial and pulmonary papillomatosis without involvement of the larynx treated with intravenous Bevacizumab in a child

G Cuestas, V Rodríguez, F Doormann - Archivos Argentinos de …, 2019 - europepmc.org
Recurrent respiratory papillomatosis is an infrequent benign neoplasm that commonly
affects the upper airway with a predilection for the larynx. Isolated tracheobronchial …

Novel treatments for recurrent respiratory papillomatosis

C Armbruster - Expert Opinion on Investigational Drugs, 2002 - Taylor & Francis
Recurrent respiratory papillomatosis is a rare but often severe disease. Although benign in
histology, epithelial proliferations may result in progressive hoarseness, stridor, obstruction …

[HTML][HTML] Epidermal growth factor receptor inhibitor therapy for recurrent respiratory papillomatosis

MM Moldan, BC Bostrom, RJ Tibesar, TA Lander… - …, 2013 - ncbi.nlm.nih.gov
The epidermal growth factor pathway has been implicated in various tumors, including
human papillomavirus (HPV) lesions such as recurrent respiratory papillomatosis (RRP) …

Recurrent respiratory papillomatosis

ML Alkotob, MM Budev, AC Mehta - Journal of Bronchology & …, 2004 - journals.lww.com
Recurrent respiratory papillomatosis (RRP) caused by human papilloma virus (HPV) 6 and
11 is the most common tumor of the larynx in adults and children. Although thought to be …

Prospective, multi‐center study of the anatomic distribution of recurrent respiratory papillomatosis

PA Benedict, A Kravietz, E Achlatis, B Wang… - The …, 2022 - Wiley Online Library
Objectives/Hypothesis To create a model of the anatomic distribution, recurrence, and
growth patterns of recurrent respiratory papillomatosis (RRP). Study Design Prospective …

VEGF as a Key Actor in Recurrent Respiratory Papillomatosis: A Narrative Review

S Gazzini, R Cerullo, D Soloperto - Current Issues in Molecular Biology, 2024 - mdpi.com
Recurrent respiratory papillomatosis (RRP) is a benign disease of the upper aerodigestive
tract caused by human papillomavirus (HPV) types 6 and 11. The clinical course is …